Federal Register #DEA-1764

DEA Notice: Importer Registration Application for Marihuana (PCI Pharma Services)

The Drug Enforcement Administration (DEA), part of the Department of Justice, has announced a notice regarding an application for importer registration of controlled substances. - Government Buyer: - Drug Enforcement Administration (DEA), Department of Justice - OEM/Vendor: - AndersonBrecon, Inc DBA PCI Pharma Services - Products/Services Requested: - Marihuana (drug code 7360) - Intended for analytical and clinical research trials - No other substances or activities authorized - Not for importation of finished dosage forms for commercial sale - Unique/Notable Requirements: - DEA is soliciting comments and objections from registered bulk manufacturers and applicants - Registration is strictly limited to research purposes, excluding commercial sales - Only AndersonBrecon, Inc DBA PCI Pharma Services is mentioned as the applicant/vendor - No additional OEMs, vendors, or product/service line items are referenced in the notice.

Description

AndersonBrecon, Inc DBA PCI Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s), specifically Marihuana (drug code 7360) for use in analytical and clinical research trials. No other activities for this drug code are authorized for this registration. Comments and objections to the issuance of the proposed registration are due by October 8, 2026. Interested parties may submit comments electronically or file a written request for a hearing by the same date.

View original listing